Advertisement
Screener

CANDEL THERAPEUTICS, INC. (CADL) ROI

CANDEL THERAPEUTICS, INC. (CADL) ROI

  • 2024-12-31: ROI -70.78%.
  • 2024-09-30: ROI 4419.90%.
  • 2024-06-30: ROI -764.11%.
  • 2024-03-31: ROI -149.94%.

Complete source-backed roi history.

Available history
2023-03-31 to 2024-12-31
Data captured

Historical ROI

DateROI
2024-12-31-70.78%
2024-09-304419.90%
2024-06-30-764.11%
2024-03-31-149.94%
2023-12-31-114.03%
2023-09-30-73.46%
2023-06-30-62.94%
2023-03-31-44.58%

Annual ROI

DateROI
2024-12-31-70.78%
2023-12-31-114.03%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sana Biotechnology, Inc. (SANA)United States$0.886B-4.92
Attovia Therapeutics, Inc. (ATTO)United States$0.828B
Odyssey Therapeutics, Inc. (ODTX)United States$0.960B
Solid Biosciences Inc. (SLDB)United States$0.802B-5.07
Cullinan Therapeutics, Inc. (CGEM)United States$0.993B-5.72
Monte Rosa Therapeutics, Inc. (GLUE)United States$1.002B-12.81
4D Molecular Therapeutics, Inc. (FDMT)United States$0.733B-4.10
MeiraGTx Holdings plc (MGTX)United States$1.061B16.10
Vor Biopharma Inc. (VOR)United States$1.091B1.60
Aura Biosciences, Inc. (AURA)United States$0.639B-5.61